Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice

Metabolism. 2001 Nov;50(11):1282-5. doi: 10.1053/meta.2001.27198.

Abstract

To clarify the mechanisms of impaired insulin secretion in Nagoya-Shibata-Yasuda (NSY) mice, an inbred strain of mice with spontaneous development of type 2 (non-insulin-dependent) diabetes mellitus, the insulin response to glucose (5.5 to 27.8 mmol/L) and nonglucose stimuli (glibenclamide, arginine, and BayK8644, a Ca-channel opener) was studied in vitro using isolated islets from male NSY and control C3H/He mice at 36 weeks of age by the batch incubation method. Insulin response to 5.5 mmol/L glucose was not significantly different between NSY and C3H/He mice, but insulin response to a high concentration of glucose (> or = 11.1 mmol/L) was significantly smaller in NSY mice than in control C3H/He mice. The dose-response curve of insulin secretion showed a markedly reduced maximum response, but almost normal glucose sensitivity in NSY islets. Insulin responses to glibenclamide (1 mmol/L), arginine (20 mmol/L), and BayK8644 (0.1 mmol/L) were also significantly smaller in NSY mice than in C3H/He mice. Insulin content of islets, in contrast, was significantly higher in NSY mice than in C3H/He mice. The impaired insulin response to glucose and nonglucose stimuli together with higher insulin content in islets in the NSY mouse suggest that a defect in voltage-dependent Ca(2+)-channel or thereafter in the cascade of insulin secretion may be responsible for impaired insulin secretion in NSY mice. NSY mice, therefore, could be a novel animal model of type 2 diabetes with a defect in insulin secretion at a different site from that in previously known animal models.

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Animals
  • Arginine / pharmacology
  • Blood Glucose / drug effects
  • Calcium Channel Agonists / pharmacology
  • Cell Separation
  • Diabetes Mellitus, Experimental / physiopathology*
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Glucose / pharmacology*
  • Glucose Tolerance Test
  • Glyburide / pharmacology
  • Hypoglycemic Agents / pharmacology
  • In Vitro Techniques
  • Insulin / analysis
  • Insulin / blood*
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / chemistry
  • Islets of Langerhans / metabolism
  • Male
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred Strains
  • Stimulation, Chemical

Substances

  • Blood Glucose
  • Calcium Channel Agonists
  • Hypoglycemic Agents
  • Insulin
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Arginine
  • Glucose
  • Glyburide